Bank of New York Mellon’s Antares Pharma, Inc. ATRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-736,241
Closed -$3.02M 4767
2022
Q1
$3.02M Buy
736,241
+17,151
+2% +$70.3K ﹤0.01% 2698
2021
Q4
$2.57M Buy
719,090
+123,262
+21% +$440K ﹤0.01% 2840
2021
Q3
$2.17M Buy
595,828
+24,787
+4% +$90.2K ﹤0.01% 2934
2021
Q2
$2.49M Sell
571,041
-105,664
-16% -$461K ﹤0.01% 2853
2021
Q1
$2.78M Sell
676,705
-14,628
-2% -$60.1K ﹤0.01% 2734
2020
Q4
$2.76M Buy
691,333
+44,409
+7% +$177K ﹤0.01% 2658
2020
Q3
$1.75M Sell
646,924
-1,621
-0.2% -$4.38K ﹤0.01% 2750
2020
Q2
$1.78M Buy
648,545
+19,176
+3% +$52.7K ﹤0.01% 2749
2020
Q1
$1.49M Sell
629,369
-176,850
-22% -$417K ﹤0.01% 2706
2019
Q4
$3.79M Buy
806,219
+178,354
+28% +$838K ﹤0.01% 2474
2019
Q3
$2.1M Sell
627,865
-10,738
-2% -$35.9K ﹤0.01% 2733
2019
Q2
$2.1M Buy
638,603
+18,111
+3% +$59.6K ﹤0.01% 2771
2019
Q1
$1.88M Sell
620,492
-16,419
-3% -$49.7K ﹤0.01% 2802
2018
Q4
$1.73M Buy
636,911
+138,756
+28% +$378K ﹤0.01% 2796
2018
Q3
$1.67M Sell
498,155
-17,927
-3% -$60.2K ﹤0.01% 2950
2018
Q2
$1.33M Sell
516,082
-47,049
-8% -$121K ﹤0.01% 3090
2018
Q1
$1.24M Buy
563,131
+17,345
+3% +$38.2K ﹤0.01% 3095
2017
Q4
$1.09M Buy
545,786
+9,661
+2% +$19.2K ﹤0.01% 3193
2017
Q3
$1.74M Buy
536,125
+10,619
+2% +$34.4K ﹤0.01% 2918
2017
Q2
$1.69M Buy
525,506
+357,991
+214% +$1.15M ﹤0.01% 2947
2017
Q1
$476K Buy
167,515
+28,029
+20% +$79.6K ﹤0.01% 3570
2016
Q4
$325K Sell
139,486
-15,412
-10% -$35.9K ﹤0.01% 3756
2016
Q3
$260K Sell
154,898
-88,159
-36% -$148K ﹤0.01% 3815
2016
Q2
$256K Sell
243,057
-334,216
-58% -$352K ﹤0.01% 3806
2016
Q1
$502K Buy
577,273
+3,220
+0.6% +$2.8K ﹤0.01% 3433
2015
Q4
$694K Sell
574,053
-241,026
-30% -$291K ﹤0.01% 3367
2015
Q3
$1.39M Sell
815,079
-16,194
-2% -$27.5K ﹤0.01% 2965
2015
Q2
$1.73M Buy
831,273
+130,077
+19% +$271K ﹤0.01% 3014
2015
Q1
$1.9M Buy
701,196
+36,626
+6% +$99.2K ﹤0.01% 2901
2014
Q4
$1.71M Sell
664,570
-690
-0.1% -$1.77K ﹤0.01% 2972
2014
Q3
$1.22M Sell
665,260
-284,776
-30% -$521K ﹤0.01% 3177
2014
Q2
$2.54M Buy
950,036
+27,294
+3% +$72.9K ﹤0.01% 2754
2014
Q1
$3.23M Buy
922,742
+98,979
+12% +$346K ﹤0.01% 2572
2013
Q4
$3.68M Buy
823,763
+90,110
+12% +$403K ﹤0.01% 2484
2013
Q3
$2.98M Buy
733,653
+92,863
+14% +$377K ﹤0.01% 2571
2013
Q2
$2.67M Buy
+640,790
New +$2.67M ﹤0.01% 2599